Laryngeal Plasmacytosis Responsive to Inhaled Budesonide
- 8 August 2022
- journal article
- editorial
- Published by Wiley in The Laryngoscope
- Vol. 133 (1) , 70-72
Abstract
Mucous membrane plasmacytosis (MMP) is rare condition characterized by diffuse plasma cell infiltration of upper aero‐digestive tract mucosa. It results in epithelial hyperplasia that has a classic papillary appearance. We describe a case of MMP primarily affect laryngeal and oropharyngeal mucosa resulting in progressive airway obstruction. We highlight airway management and histopathology. The patient had near complete clinical response with inhaled budesonide, which has not yet been described as a treatment option in the literature. Laryngoscope, 133:70–72, 2023Keywords
This publication has 5 references indexed in Scilit:
- The Safety and Efficacy of Transnasal Humidified Rapid‐Insufflation Ventilatory Exchange for Laryngologic SurgeryThe Laryngoscope, 2020
- Laryngeal mucous membrane plasmacytosis with 15 year follow-up: Case report and literature reviewLeukemia Research Reports, 2020
- Circumorificial plasmacytosis/plasma cell orificial mucositis: a case series and a review of the literatureOral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 2016
- Molecular and clinical pharmacology of intranasal corticosteroids: clinical and therapeutic implicationsAllergy, 2008
- Mucous membrane plasmacytosis: A case report and review of the literatureDermatology Online Journal, 2003